Brave Asset Management’s Eli Lilly LLY Stock Holding History

Brave Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.08M	Hold	1,737	–	–	0.45%	26
2026 Q1	$1.6M	Hold	1,737	–	–	0.37%	34
2025 Q4	$1.87M	Sell	1,737 -144	-8%	-$138K	0.44%	29
2025 Q3	$1.44M	Hold	1,881	–	–	0.35%	35
2025 Q2	$1.47M	Sell	1,881 -188	-9%	-$146K	0.4%	32
2025 Q1	$1.71M	Buy	2,069 +221	+12%	+$184K	0.53%	28
2024 Q4	$1.43M	Sell	1,848 -30	-2%	-$24.8K	0.45%	31
2024 Q3	$1.66M	Hold	1,878	–	–	0.4%	28
2024 Q2	$1.7M	Buy	1,878 +14	+0.8%	+$11.2K	0.43%	23
2024 Q1	$1.45M	Buy	1,864 +65	+4%	+$46.3K	0.38%	31
2023 Q4	$1.05M	Sell	1,799 -126	-7%	-$73.5K	0.29%	37
2023 Q3	$1.03M	Hold	1,925	–	–	0.32%	37
2023 Q2	$903K	Hold	1,925	–	–	0.26%	41
2023 Q1	$661K	Buy	1,925 +99	+5%	+$33.4K	0.21%	48
2022 Q4	$668K	Hold	1,826	–	–	0.23%	52
2022 Q3	$590K	Sell	1,826 -48	-3%	-$15.2K	0.3%	49
2022 Q2	$608K	Hold	1,874	–	–	0.27%	52
2022 Q1	$537K	Sell	1,874 -77	-4%	-$19.8K	0.18%	68
2021 Q4	$539K	Hold	1,951	–	–	0.15%	70
2021 Q3	$451K	Sell	1,951 -50	-2%	-$12.3K	0.13%	75
2021 Q2	$459K	Hold	2,001	–	–	0.14%	80
2021 Q1	$374K	Sell	2,001 -50	-2%	-$9.78K	0.13%	84
2020 Q4	$346K	Hold	2,051	–	–	0.13%	86
2020 Q3	$304K	Sell	2,051 -75	-4%	-$11.6K	0.14%	73
2020 Q2	$349K	Hold	2,126	–	–	0.18%	67
2020 Q1	$295K	Hold	2,126	–	–	0.18%	70
2019 Q4	$279K	Hold	2,126	–	–	0.14%	100
2019 Q3	$238K	Sell	2,126 -50	-2%	-$5.57K	0.14%	106
2019 Q2	$241K	Sell	2,176 -9,361	-81%	-$1.1M	0.14%	109
2019 Q1	$1.5M	Buy	11,537 +669	+6%	+$81.3K	0.83%	36
2018 Q4	$1.26M	Sell	10,868 -833	-7%	-$93.1K	0.85%	35
2018 Q3	$1.26M	Buy	11,701 +140	+1%	+$14K	0.64%	44
2018 Q2	$987K	Buy	11,561 +650	+6%	+$53.4K	0.57%	53
2018 Q1	$844K	Buy	10,911 +86	+0.8%	+$6.92K	0.51%	61
2017 Q4	$914K	Sell	10,825 -104	-1%	-$8.85K	0.48%	62
2017 Q3	$935K	Buy	10,929 +985	+10%	+$80.8K	0.49%	54
2017 Q2	$818K	Buy	9,944 +3,119	+46%	+$254K	0.44%	67
2017 Q1	$574K	Sell	6,825 -650	-9%	-$52.1K	0.34%	79
2016 Q4	$550K	Hold	7,475	–	–	0.35%	76
2016 Q3	$600K	Sell	7,475 -75	-1%	-$6K	0.38%	71
2016 Q2	$595K	Hold	7,550	–	–	0.4%	63
2016 Q1	$544K	Hold	7,550	–	–	0.38%	66
2015 Q4	$636K	Hold	7,550	–	–	0.43%	63
2015 Q3	$632K	Hold	7,550	–	–	0.48%	62
2015 Q2	$630K	Hold	7,550	–	–	0.44%	70
2015 Q1	$549K	Hold	7,550	–	–	0.38%	74
2014 Q4	$521K	Hold	7,550	–	–	0.37%	76
2014 Q3	$490K	Hold	7,550	–	–	0.36%	80
2014 Q2	$469K	Hold	7,550	–	–	0.33%	88
2014 Q1	$444K	Hold	7,550	–	–	0.35%	79
2013 Q4	$385K	Buy	+7,550	New	+$378K	0.31%	83

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ONB

Old National Bancorp Evansville, Indiana $5.02B AUM 25.65% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

GIM

Goelzer Investment Management Carmel, Indiana $2.29B AUM 39.12% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Brave Asset Management's LLY Position: Q2 2026 in Review

Brave Asset Management held its Eli Lilly (LLY) position steady in Q2 2026 at 1,737 shares worth $2.08M. The position accounts for 0.45% of the portfolio, ranked #26.

Brave Asset Management first reported a position in LLY in Q4 2013 and has held it in 51 quarters since. 1,857 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Brave Asset Management held 1,737 shares of Eli Lilly worth $2.08M as of Q2 2026.
Brave Asset Management left its Eli Lilly share count unchanged in Q2 2026.
Eli Lilly made up 0.45% of Brave Asset Management's portfolio in Q2 2026, its #26 holding.
Brave Asset Management first reported a position in Eli Lilly in Q4 2013 and has held it in 51 quarters since.
1,857 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Brave Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.